Rejuvitas works on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming.
Rejuvitas has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.
Rejuvitas is headquartered in New York, United States.
Rejuvitas works on neurodegeneration and age-related neurodegenerative diseases by focusing on metabolic reprogramming.
Rejuvitas is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rejuvitas — Funding & Investors." VCBacked, September 7, 2022, https://www.vcbacked.co/company/rejuvitas. Accessed August 16, 2026.
VCBacked. (2022). Rejuvitas — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/rejuvitas
{{cite web |title=Rejuvitas — Funding & Investors |url=https://www.vcbacked.co/company/rejuvitas |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated